Aleksandr Lazaryan

Aleksandr Lazaryan

UNVERIFIED PROFILE

Are you Aleksandr Lazaryan?   Register this Author

Register author
Aleksandr Lazaryan

Aleksandr Lazaryan

Publications by authors named "Aleksandr Lazaryan"

Are you Aleksandr Lazaryan?   Register this Author

43Publications

1188Reads

38Profile Views

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2019 09 26. Epub 2019 Sep 26.

Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
September 2019

Impressive response of CD30-negative, treatment-refractory mycosis fungoides to brentuximab vedotin.

Dermatol Ther 2019 03 17;32(2):e12835. Epub 2019 Feb 17.

Moffitt Cancer Center, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.12835DOI Listing
March 2019

Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index.

Biol Blood Marrow Transplant 2017 Sep 15;23(9):1485-1490. Epub 2017 May 15.

Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586072PMC
September 2017

Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma.

Int J Radiat Oncol Biol Phys 2017 09 15;99(1):94-102. Epub 2017 May 15.

Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.05.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744586PMC
September 2017

EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.

Mod Pathol 2016 10 22;29(10):1200-11. Epub 2016 Jul 22.

The James Homer Wright Pathology Laboratories of the Massachusetts General Hospital, and The Department of Pathology, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2016.130DOI Listing
October 2016

Expecting a Miracle Harvest after Miracle Growth: Controversies of Granulocyte Colony-Stimulating Factor-Mobilized Matched Sibling Donor Transplantation.

Biol Blood Marrow Transplant 2016 08 14;22(8):1343-1345. Epub 2016 Jun 14.

Hematology, Oncology, Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.06.009DOI Listing
August 2016

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2016 May 29;22(5):879-83. Epub 2015 Dec 29.

Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.12.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922492PMC
May 2016

Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.

Clin Transplant 2016 Jan;30(1):60-5

Division of Renal Diseases and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.12659DOI Listing
January 2016

Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).

Biol Blood Marrow Transplant 2012 Jun 29;18(6):874-80. Epub 2011 Oct 29.

Taussig Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387911100457
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.10.032DOI Listing
June 2012

Can G-CSF cause leukemia in hematopoietic stem cell donors?

Biol Blood Marrow Transplant 2011 Dec 13;17(12):1739-46. Epub 2011 Jul 13.

The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.07.003DOI Listing
December 2011

Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia.

Cancer 2010 Aug;116(15):3614-20

Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25086DOI Listing
August 2010

Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression.

AIDS 2006 Aug;20(12):1583-90

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0022, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.aids.0000238403.08497.3fDOI Listing
August 2006